226 related articles for article (PubMed ID: 35022662)
1. Hyperresponsive cytosolic DNA-sensing pathway in monocytes from primary Sjögren's syndrome.
Huijser E; Bodewes ILA; Lourens MS; van Helden-Meeuwsen CG; van den Bosch TPP; Grashof DGB; van de Werken HJG; Lopes AP; van Roon JAG; van Daele PLA; Brkic Z; Dik WA; Versnel MA
Rheumatology (Oxford); 2022 Aug; 61(8):3491-3496. PubMed ID: 35022662
[TBL] [Abstract][Full Text] [Related]
2. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
[TBL] [Abstract][Full Text] [Related]
3. Contrasting expression pattern of RNA-sensing receptors TLR7, RIG-I and MDA5 in interferon-positive and interferon-negative patients with primary Sjögren's syndrome.
Maria NI; Steenwijk EC; IJpma AS; van Helden-Meeuwsen CG; Vogelsang P; Beumer W; Brkic Z; van Daele PL; van Hagen PM; van der Spek PJ; Drexhage HA; Versnel MA
Ann Rheum Dis; 2017 Apr; 76(4):721-730. PubMed ID: 27672125
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mTOR suppresses IFNα production and the STING pathway in monocytes from systemic lupus erythematosus patients.
Murayama G; Chiba A; Kuga T; Makiyama A; Yamaji K; Tamura N; Miyake S
Rheumatology (Oxford); 2020 Oct; 59(10):2992-3002. PubMed ID: 32160289
[TBL] [Abstract][Full Text] [Related]
5. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
[TBL] [Abstract][Full Text] [Related]
6. Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?
Wahadat MJ; Bodewes ILA; Maria NI; van Helden-Meeuwsen CG; van Dijk-Hummelman A; Steenwijk EC; Kamphuis S; Versnel MA
Arthritis Res Ther; 2018 Jan; 20(1):4. PubMed ID: 29321042
[TBL] [Abstract][Full Text] [Related]
7. MxA as a clinically applicable biomarker for identifying systemic interferon type I in primary Sjogren's syndrome.
Maria NI; Brkic Z; Waris M; van Helden-Meeuwsen CG; Heezen K; van de Merwe JP; van Daele PL; Dalm VA; Drexhage HA; Versnel MA
Ann Rheum Dis; 2014 Jun; 73(6):1052-9. PubMed ID: 23831963
[TBL] [Abstract][Full Text] [Related]
8. Serum interferon-α2 measured by single-molecule array associates with systemic disease manifestations in Sjögren's syndrome.
Huijser E; Göpfert J; Brkic Z; van Helden-Meeuwsen CG; Jansen S; Mandl T; Olsson P; Schrijver B; Schreurs MWJ; van Daele PLA; Dik WA; Versnel MA
Rheumatology (Oxford); 2022 May; 61(5):2156-2166. PubMed ID: 34505866
[TBL] [Abstract][Full Text] [Related]
9. Plasmacytoid DCs From Patients With Sjögren's Syndrome Are Transcriptionally Primed for Enhanced Pro-inflammatory Cytokine Production.
Hillen MR; Pandit A; Blokland SLM; Hartgring SAY; Bekker CPJ; van der Heijden EHM; Servaas NH; Rossato M; Kruize AA; van Roon JAG; Radstake TRDJ
Front Immunol; 2019; 10():2096. PubMed ID: 31552042
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression.
Brkic Z; Maria NI; van Helden-Meeuwsen CG; van de Merwe JP; van Daele PL; Dalm VA; Wildenberg ME; Beumer W; Drexhage HA; Versnel MA
Ann Rheum Dis; 2013 May; 72(5):728-35. PubMed ID: 22736090
[TBL] [Abstract][Full Text] [Related]
11. Trained Immunity in Primary Sjögren's Syndrome: Linking Type I Interferons to a Pro-Atherogenic Phenotype.
Huijser E; van Helden-Meeuwsen CG; Grashof DGB; Tarn JR; Brkic Z; Huisman JMA; Wahadat MJ; van de Werken HJG; Lopes AP; van Roon JAG; van Daele PLA; Kamphuis S; Ng WF; Bekkering S; Joosten LAB; Dik WA; Versnel MA
Front Immunol; 2022; 13():840751. PubMed ID: 35860283
[TBL] [Abstract][Full Text] [Related]
12. Exploring the shared molecular mechanisms between systemic lupus erythematosus and primary Sjögren's syndrome based on integrated bioinformatics and single-cell RNA-seq analysis.
Cui Y; Zhang H; Wang Z; Gong B; Al-Ward H; Deng Y; Fan O; Wang J; Zhu W; Sun YE
Front Immunol; 2023; 14():1212330. PubMed ID: 37614232
[TBL] [Abstract][Full Text] [Related]
13. Activation of Toll-like receptor 7 signaling in labial salivary glands of primary Sjögren's syndrome patients.
Shimizu T; Nakamura H; Takatani A; Umeda M; Horai Y; Kurushima S; Michitsuji T; Nakashima Y; Kawakami A
Clin Exp Immunol; 2019 Apr; 196(1):39-51. PubMed ID: 30446998
[TBL] [Abstract][Full Text] [Related]
14. Association of Abnormal Elevations in IFIT3 With Overactive Cyclic GMP-AMP Synthase/Stimulator of Interferon Genes Signaling in Human Systemic Lupus Erythematosus Monocytes.
Wang J; Dai M; Cui Y; Hou G; Deng J; Gao X; Liao Z; Liu Y; Meng Y; Wu L; Yao C; Wang Y; Qian J; Guo Q; Ding H; Qu B; Shen N
Arthritis Rheumatol; 2018 Dec; 70(12):2036-2045. PubMed ID: 29806091
[TBL] [Abstract][Full Text] [Related]
15. The Transcriptomic Profile of Monocytes from Patients With Sjögren's Syndrome Is Associated With Inflammatory Parameters and Is Mimicked by Circulating Mediators.
Lopes AP; Bekker CPJ; Hillen MR; Blokland SLM; Hinrichs AC; Pandit A; Kruize AA; Radstake TRDJ; van Roon JAG
Front Immunol; 2021; 12():701656. PubMed ID: 34413853
[TBL] [Abstract][Full Text] [Related]
16. Identification of key interferon-stimulated genes for indicating the condition of patients with systemic lupus erythematosus.
Shen M; Duan C; Xie C; Wang H; Li Z; Li B; Wang T
Front Immunol; 2022; 13():962393. PubMed ID: 35967341
[TBL] [Abstract][Full Text] [Related]
17. PANoptosis Features, a Humanized NSG Murine Model of Sjogren's Syndrome.
Yang Y; Zhang H; Xiao X; Guo M
DNA Cell Biol; 2024 May; 43(5):207-218. PubMed ID: 38635961
[TBL] [Abstract][Full Text] [Related]
18. B-cell activating factor of the tumour necrosis factor family expression in blood monocytes and T cells from patients with primary Sjögren's syndrome.
Lavie F; Miceli-Richard C; Ittah M; Sellam J; Gottenberg JE; Mariette X
Scand J Immunol; 2008 Feb; 67(2):185-92. PubMed ID: 18201372
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor of IkappaB kinase activity, BAY 11-7082, interferes with interferon regulatory factor 7 nuclear translocation and type I interferon production by plasmacytoid dendritic cells.
Miyamoto R; Ito T; Nomura S; Amakawa R; Amuro H; Katashiba Y; Ogata M; Murakami N; Shimamoto K; Yamazaki C; Hoshino K; Kaisho T; Fukuhara S
Arthritis Res Ther; 2010; 12(3):R87. PubMed ID: 20470398
[TBL] [Abstract][Full Text] [Related]
20. Primary Sjögren's syndrome and the type I interferon system.
Nordmark G; Eloranta ML; Ronnblom L
Curr Pharm Biotechnol; 2012 Aug; 13(10):2054-62. PubMed ID: 22208657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
